Drug Compounder Shut Down in Response to FDA Complaint of Potential Contamination

Drug Industry Daily
A A
A federal judge shut down a Salt Lake City drug compounder Aug. 3 under a consent decree issued in a case brought by the FDA after inspections uncovered numerous regulatory violations.

To View This Article:

Login

Subscribe To Drug Industry Daily